Lilach Agemy
Weizmann Institute of Science, Israel
Biography
Dr. Lilach Agemy has her expertise in vascular biology and tumor/ atherosclerosis microenvironment. Developed highly specific delivery of different probes and drugs for cancer/ atherosclerosis therapy with hands on experience in the synthesis, modification, and characterization of different nanoparticles systems including magnetic iron based nanoparticles. Her current research focuses on using new targeted derivatives for photodynamic therapy with bacteriochlorophyll that were developed in our lab and based on TOOKAD, which was recently approved by EMA. Dr. Agemy is working in an extensively multidisciplinary environment involving Biologists, Chemists, Physicists and Bioengineers with participation ranging from designing, performing experiments, analyzing imaging and other biological data, and is involved in training graduate students and postdocs.